Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies.
Familial comorbidity of bipolar disorder and multiple sclerosis: Genetic susceptibility, coexistence or causal relationship?
The cuprizone model: regional heterogeneity of pathology.
Psychometric Properties of the Arab Heritage Activity Card Sort.
Association Between MTHFR Genetic Variants and Multiple Sclerosis in a Southern Iranian Population.
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis.
Effect of Vitamin A Supplementation on fatigue and depression in Multiple Sclerosis patients: A Double-Blind Placebo-Controlled Clinical Trial.
Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma.
Evidence against the Involvement of Chronic Cerebrospinal Venous Abnormalities in Multiple Sclerosis. A Case-Control Study.
Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms.
Complete bilateral horizontal internuclear ophthalmoplegia as a sign of multiple sclerosis relapse.
Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress.
Alemtuzumab for multiple sclerosis: who and when to treat?
Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients.
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study.
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
Immunological differences between classical phenothypes of multiple sclerosis.
Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
How safe could intrathecal transplantation of mesenchymal stem cells be considered in multiple sclerosis?-Reply.
Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS.
Detection of reduced interhemispheric cortical communication during task execution in multiple sclerosis patients using functional near-infrared spectroscopy.
Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis.
Sacral nerve stimulation for neurogenic bladder.
Incidence of multiple sclerosis in multiple racial and ethnic groups.

Pages